Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1Terminated 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Anomalies 1Salpingitis 1Primary Ovarian Insufficiency 1Pregnancy, Ectopic 1Polycystic Ovary Syndrome 1Leiomyoma 1Infertility, Female 1Infertility 1Endometritis 1Endometriosis 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 328Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 280Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × OTHER × LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- × Clear all
NCT04071574 2023-05-09

CS-EOSP-ICSI

Lebanese University

Phase 1/2 Completed
200 enrolled
Gynecologic

Uterine Anomalies, Endometriosis, Endometritis, Infertility, Infertility, Female, Leiomyoma, Polycystic Ovary Syndrome, Pregnancy, Ectopic, Salpingitis, Primary Ovarian Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡